Insulet, a medical device company, has reported positive results from the first feasibility study of its Omnipod Horizon hybrid closed-loop system for the treatment of patients with type 1 diabetes.
19 February 2017
9 February 2017
Medical devices firm EnteroMedics has published positive three-year data from its VBLOC DM2 study of vBloc neurometabolic therapy in obese patients with Type 2 diabetes, in the Journal of Diabetes...
25 January 2017
US-based Dexcom has published positive results for the continuous glucose monitoring (CGM) study (DiaMonD) conducted in diabetes patients on multiple daily injections (MDI) insulin therapy.
15 November 2016
US-based developer, manufacturer and distributor of continuous glucose monitoring systems, Dexcom has opened its Europe, Middle East and Africa (EMEA) headquarters in Edinburgh, Scotland.
20 October 2016
Ascensia Diabetes Care has launched the CONTOUR NEXT ONE blood glucose monitoring system (BGMS) in the UK.
4 February 2016
Panasonic completed the acquisition of Bayer for €1bn, Boston Scientific launched LithoVue single-use digital flexible ureteroscope. Medicaldevice-network.com wraps-up the key headlines from January.
5 January 2016
Panasonic Healthcare Holdings has completed the acquisition of German diabetes care business Bayer for JPY132bn (€1bn).
12 August 2015
DexCom has signed an agreement with Google's life sciences team to jointly develop a series of next-generation continuous glucose monitoring (CGM) products for diabetes management.
2 July 2015
The University of California Santa Barbara (UCSB) scientists have developed an implantable artificial pancreas, which continuously measures a patient's glucose level and can automatically release insulin as needed.
10 June 2015
Bayer has signed a definitive agreement to divest its Diabetes Care business to Panasonic Healthcare for €1.2bn.